STANDARD BIOTOOLS INC - NOTE 2.750% 2/0

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Debt / NOTE 2.750% 2/0
Market price (% of par)
92.49%
Total 13F principal
$48,737,000
Principal change
+$85,000
Total reported market value
$44,919,000
Number of holders
13
Value change
+$686,685
Number of buys
5
Number of sells
6

Institutional Holders of STANDARD BIOTOOLS INC - NOTE 2.750% 2/0 as of Q4 2018

As of 31 Dec 2018, STANDARD BIOTOOLS INC - NOTE 2.750% 2/0 was held by 13 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $48,737,000 in principal (par value) of the bond. The largest 10 bondholders included Indaba Capital Management, L.P., SYMPHONY ASSET MANAGEMENT LLC, Bruce & Co., Inc., Endurant Capital Management LP, CITADEL ADVISORS LLC, Partner Fund Management, L.P., SMH CAPITAL ADVISORS INC, CSS LLC/IL, ENVESTNET ASSET MANAGEMENT INC, and MORGAN STANLEY. This page lists 13 institutional bondholders reporting positions for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.